Soluna Regains Compliance with Nasdaq Listing Requirements
ALBANY, N.Y.–(BUSINESS WIRE)–$SLNH #SLNH—Soluna Holdings, Inc. (“Soluna” or the “Company”) (NASDAQ: SLNH), a developer of green data centers... Read more.
Lincoln Electric Schedules Webcast for Third Quarter 2025 Results
CLEVELAND–(BUSINESS WIRE)–#LEA–Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) announced today that it will release its third... Read more.
Aqemia to Participate in Jefferies European Disruptive Tech Conference
LONDON–(BUSINESS WIRE)–Aqemia, a pioneering TechBio company leveraging advanced physics and generative AI for drug discovery, announced that its CEO... Read more.
International Trade Finance Course | Explore the Roles of Commercial Banks, Settlement Methods, INCOTERMS 2020, Risk Mitigation, and Financing Solutions (November 17-19, 2025) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “International Trade Finance (November 17-19, 2025)” training has been added to ResearchAndMarkets.com’s... Read more.
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
Furthers Global Leadership in Donor Organ and Transplant Recipient HLA Typing SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA)... Read more.
Cognitiv Invites Marketers to ‘Meet Edna’ in Major Brand Campaign Launching at Advertising Week New York
Campaign showcases the power of unexpected, valuable audience insights from Cognitiv’s Deep Learning Advertising Platform NEW YORK–(BUSINESS WIRE)–Cognitiv,... Read more.
Cell and Gene Therapies on the Rise: New Report Reveals Growing Adoption and Persistent Challenges
Oncologists’ experience and familiarity with CGTs has increased over last year, but concerns persist with 66% saying patients view CGTs as “too experimental”... Read more.
OneMedNet Selects Palantir to Advance Healthcare AI and Data Analytics
DENVER & MINNEAPOLIS–(BUSINESS WIRE)–OneMedNet Corporation (Nasdaq: ONMD) has selected Palantir Technologies (Nasdaq: PLTR) to transform the healthcare... Read more.
Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases
Tulisokibart, an investigational anti-TL1A monoclonal antibody currently in Phase 3 trials for ulcerative colitis and Crohn’s disease, to be studied in hidradenitis... Read more.
Eaton Names Kaled Awada Executive Vice President and Chief Human Resources Officer
DUBLIN–(BUSINESS WIRE)–Intelligent power management company Eaton (NYSE:ETN) today announced that Kaled Awada has been named executive vice president... Read more.